Neuroscience in Biopharma: Innovation Through Biology & De-Risking CNS Programs: Progress & Outlook

• Exploring Lundbeck’s evolution and outlook within neuroscience
• Lundbeck R&D tactics for pipeline derisking through rigorous development process
• Spotlighting on Lundbeck’s pipeline innovation and importance of collaborations and partnerships to advance neuroscience

Speakers:

Karina Krøjer

Head of Asia Drug Development

Lundbeck